Bevacizumab (Avastin) Biosimilars — Save Thousands
FDA-approved biosimilars for Bevacizumab (Avastin) offer the same efficacy and safety at up to 50% lower cost — saving up to $4,000/year. Script Unlock connects you with pharmacies offering biosimilar pricing.
Reference product
$8,000
Bevacizumab (Avastin)
Biosimilar price
from $4,000
save up to 50%
FDA-Approved Bevacizumab (Avastin) Biosimilars
MvasiZirabev
Are Biosimilars as Effective as Bevacizumab (Avastin)?
- FDA requires biosimilars to have no clinically meaningful differences in safety or efficacy
- Same active ingredient, same mechanism of action
- Interchangeable biosimilars can be substituted without prescriber intervention
- Extensive clinical studies required before FDA approval